Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners

Published:2018-06-27 Issue:4 Volume:5 Page:383-393
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Movement Disorders Clinical Practice

Author:

Burack Michelle¹,Aldred Jason²,Zadikoff Cindy³,Vanagunas Arvydas³,Klos Kevin⁴,Bilir Bahri⁵,Fernandez Hubert H.⁶,Standaert David G.⁷^ORCID

Affiliation:

1. University of Rochester Medical Center; Rochester New York USA

2. Northwest Neurological; Spokane Washington USA

3. Northwestern University Feinberg School of Medicine; Northwestern Memorial Hospital; Chicago Illinois USA

4. Movement Disorder Center of Oklahoma; Tulsa Oklahoma USA

5. Rocky Mountain Gastroenterology; Littleton Colorado USA

6. Cleveland Clinic; Cleveland Ohio USA

7. University of Alabama at Birmingham; Birmingham Alabama USA

Funder

AbbVie, Inc.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mdc3.12630/fullpdf

Reference36 articles.

1. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results;Fernandez;Mov Disord,2015

2. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study;Olanow;Lancet Neurol,2014

3. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes;Antonini;Parkinsonism Relat Disord,2015

4. Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study;Lopiano;Neurol Sci,2016

5. Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease;Valldeoriola;Neurodegener Dis Manag,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience;Journal of Neural Transmission;2024-05-15

2. Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson’s disease patients;Scientific Reports;2024-02-14

3. Levodopa-carbidopa intestinal gel infusion in Parkinson's disease;International Review of Movement Disorders;2024

4. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease;Neuropsychiatric Disease and Treatment;2023-09

5. Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty;Journal of Neural Transmission;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3